Metropolitan Life Insurance CO Pliant Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$14.14 - $19.59 $6,066 - $8,404	-429 Reduced 12.33%	3,049 $45,000
Q3 2023 Nov 14, 2023	BUY	$14.58 - $20.15 $5,671 - $7,838	389 Added 12.59%	3,478 $60,000
Q2 2023 Aug 10, 2023	BUY	$18.12 - $30.56 $55,972 - $94,399	3,089 New	3,089 $55,000
Q1 2022 May 12, 2022	SELL	$7.01 - $14.1 $51,243 - $103,071	-7,310 Closed	0 $0
Q4 2021 Jun 21, 2023	BUY	$12.27 - $18.26 $89,693 - $133,480	7,310 New	7,310 $98,000
Q3 2021 Jun 21, 2023	BUY	$16.48 - $28.98 $120,468 - $211,843	7,310 New	7,310 $123,000
Q2 2021 Jun 21, 2023	BUY	$28.05 - $37.69 $205,045 - $275,513	7,310 New	7,310 $212,000
Q2 2021 Mar 30, 2023	BUY	$28.05 - $37.69 $10,154 - $13,643	362 Added 5.21%	7,310 $212,000
Q2 2021 Aug 16, 2021	BUY	$28.05 - $37.69 $204,849 - $275,250	7,303 Added 104328.57%	7,310 $213,000
Q1 2021 Jun 26, 2023	BUY	$24.52 - $40.23 $170,364 - $279,518	6,948 New	6,948 $273 Million
Q1 2021 Mar 30, 2023	BUY	$24.52 - $40.23 $88,296 - $144,868	3,601 Added 107.59%	6,948 $273,000
Q1 2021 May 14, 2021	SELL	$24.52 - $40.23 $81,896 - $134,368	-3,340 Reduced 99.79%	7 $273,000
Q4 2020 Jun 22, 2023	BUY	$19.89 - $32.99 $66,571 - $110,417	3,347 New	3,347 $76,000
Q3 2020 Jun 26, 2023	BUY	$21.54 - $29.53 $72,094 - $98,836	3,347 New	3,347 $75,000
Q3 2020 Mar 30, 2023	BUY	$21.54 - $29.53 $72,094 - $98,836	3,347 New	3,347 $75,000
Q3 2020 Nov 13, 2020	BUY	$21.54 - $29.53 $72,094 - $98,836	3,347 New	3,347 $76,000

168

63.2M

245K

373K

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $600M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.